Navigation Links
AWT Management Announce Aggressive Growth and Acquisition Strategy
Date:9/7/2007

SOMERSET, N.J., Sept. 7 /PRNewswire-FirstCall/ -- AWT, Inc. (Pink Sheets: AWTM), a distributor of state-of-the-art medical equipment to the healthcare industry, announced today an aggressive revenue growth and acquisition strategy for the next 36 months. "With the new management team and board of directors in place, the company felt it necessary to let its shareholders know of the future of their investments," stated Christopher J. Neill, CEO. Continuing his statement, "Part of our Strategy is continually researching the market for new opportunities in acquisitions, new state-of- the-art equipment, new joint ventures, or simply increasing sales. Bringing these and additional areas of business together we feel will enhance shareholder value, and for the first third of our strategy, we have identified several acquisition targets for our focus."

The Company is presently in process of closing the first of several planned and in-process acquisitions. "As we finish this first acquisition and after we implement cost controls, AWT should show an approximate 30% increase in top line revenue and a 35% increase to the bottom line net income for this particular asset. That would mean a net of $202,500 for the acquisition which would more than cover the cost of it in the first year by approximately two fold", commented Mr. Neill, CEO. Final terms are currently being negotiated and the Company hopes to close within 30 days.

"AWT's revenue growth strategy for the healthcare industry overall is about reducing costs while keeping the margins high. The premise of having a core infrastructure of state-of-the-art technologies, methodologies, or processes, is to reduce costs for the clients you are servicing. By combining both core and associated technology and processes your overall cost reduces, allowing you to service clients at a lower cost to them and a higher margin to the Company," stated Ravi Saini, Chairman of the Board.

AWT expects to add 4 more executives and up to 20 new personnel over the next 12 months of its expansion strategy. Sources at the Company have said the addition of Mr. Donald Malter as Chief Financial Officer, brings in his 19 years of business, the experience of not only Finance and Publishing to the Company, but also the experience of Venture Enterprise. Mr. Peter Murray brings 23 years of top level sales in durable medical equipment and a outstanding reputation within the healthcare industry in the Northeast. "These executives are extraordinary professionals in their respective areas of expertise," said Mr. Saini. "We are pleased to welcome their contributions to our company with these positions," he added.

The Company believes its Strategic build-out as expressed herein will be executed and achieved but understands delays in business and execution of specific strategies and or contracts or negotiations occur.

This press release consists of forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties, and actual results could differ materially from those indicated by such forward looking statements. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE AWT, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New Modality in Migraine Management
2. Self-Management Program Beneficial for Back Pain
3. Self-Management Program Beneficial for Back Pain
4. Disease Management Programs – Effective for Heart Patient
5. Effective Management Of Heart Patients
6. New advance in prostate cancer management
7. Gastrin, Much More Than The Weight Management Hormone
8. Medical Management Now Available For Miscarriage
9. Early Awareness About Weight Management Needed To Tackle Lifelong Obesity
10. Exercise For Effective Pain Management In Old People
11. Glimepiride in the medical management of Type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology: